Targeted therapy for pediatric low-grade glioma.
Juan Pablo Muñoz PérezJordi MuchartVicente Santa-María LópezMariona Suñol CapellaNoelia SalvadorSara Pérez JaumeOfelia Cruz MartínezAndrés Morales La MadridPublished in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2021)
Our experience adds to the growing data about the efficacy and tolerability of targeted therapy in patients with PLGG. When present, toxicity is mainly mild-moderate and transient. Ongoing prospective clinical trials are trying to address if its use should be advanced to first-line therapy.